文献速递前列腺癌

甘露糖受体阳性巨噬细胞浸润与前列腺癌发生及转移性去势抵抗性疾病相关

Mannose Receptor-positive Macrophage Infiltration Correlates with Prostate Cancer Onset and Metastatic Castration-resistant Disease.
PubMed 文献 · Eur Urol Oncol · 2018-10-19

研究回顾性分析192例患者的前列腺正常组织、局限性前列腺癌和转移性去势抵抗性前列腺癌(mCRPC)样本,验证CD206免疫组化检测M2巨噬细胞。结果显示CD206阳性巨噬细胞染色面积分数从正常前列腺组织、原发未治疗癌、激素初治区域淋巴结转移至mCRPC呈逐步增加,流式细胞术证实CD206阳性M2肿瘤相关巨噬细胞浸润。

要点

  • CD206阳性巨噬细胞染色面积分数从正常前列腺组织到mCRPC呈逐步增加。
  • 流式细胞术证实CD206阳性M2肿瘤相关巨噬细胞浸润。
  • 作者认为结果为难治性前列腺癌微环境中靶向巨噬细胞以增强免疫治疗反应提供依据。

核心结论

  • CD206阳性巨噬细胞从正常前列腺组织到mCRPC呈进行性增加。
  • 鉴于巨噬细胞的免疫抑制性质及前列腺癌免疫治疗缺乏临床成功,作者认为结果为难治性前列腺癌微环境中靶向巨噬细胞作为增强免疫治疗反应的潜在方法提供依据。

研究设计与样本

  • 回顾性分析192例患者的前列腺正常组织、局限性前列腺癌和mCRPC样本。
  • 分析验证检测人甘露糖受体(CD206)的免疫组化 assay 以评估M2巨噬细胞参与。

主要发现

  • 多重免疫荧光染色显示少量CD206染色与淋巴管内皮细胞共定位,绝大多数染色见于CD68阳性巨噬细胞。
  • CD206阳性巨噬细胞染色面积分数从正常(即无炎症)前列腺组织、原发未治疗癌、激素初治区域淋巴结转移至mCRPC呈逐步增加。
  • 流式细胞术补充研究证实CD206阳性M2肿瘤相关巨噬细胞浸润。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 快速尸检样本数量少。
  • 缺乏神经内分泌前列腺癌样本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: M2 tumor-associated macrophages (M2-TAMs) can suppress inflammation in the tumor microenvironment and have been reported to modulate cancer progression. We and others have previously reported M2-TAM infiltration in metastatic castration-resistant prostate cancer (mCRPC). OBJECTIVE: To determine whether the extent of M2-TAM infiltration correlates with PC aggressiveness. DESIGN, SETTING, AND PARTICIPANTS: Normal prostate tissue, localized PC, and mCRPC samples from 192 patients were retrospectively analyzed. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We analytically validated an immunohistochemistry assay for detection of the human mannose receptor (CD206) to assess M2 macrophage involvement. RESULTS AND LIMITATIONS: Multiplex immunofluorescent staining showed that a small fraction of CD206 staining co-localized with the endothelial cells of lymphatic vessels, while the vast majority of staining occurred in CD68-positive macrophages. The area fraction of staining for CD206-positive macrophages increased in a stepwise fashion from normal (ie, no inflammation) prostate tissue, to primary untreated carcinomas, to hormone-naïve regional lymph node metastases, to mCRPC. Complementary studies using flow cytometry confirmed CD206-positive M2-TAM infiltration. Limitations include the small number of rapid autopsy samples and the lack of neuroendocrine PC samples. CONCLUSIONS: Our results revealed a progressive increase in CD206-positive macrophages from normal prostate to mCRPC. Given the immunosuppressive nature of macrophages and the lack of clinical success of immunotherapy for PC patients, our results provide a rationale for therapeutic targeting of macrophages in the PC microenvironment as a potential method to augment immunotherapeutic responses. PATIENT SUMMARY: In this report we used 192 prostate cancer samples to determine if M2 macrophage infiltration is correlated with castration resistance in prostate cancer.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Zarif JC, Baena-Del Valle JA, Hicks JL, et al. Mannose Receptor-positive Macrophage Infiltration Correlates with Prostate Cancer Onset and Metastatic Castration-resistant Disease. Eur Urol Oncol. 2018. PMID: 31277779. doi:10.1016/j.euo.2018.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。